Keywords: Nycomed, Chinese acquisition, India, API plant, Zydus Cadila, Zydus Nycomed, Pantoprazole
Nycomed progresses its BRIC ambitions, soon to announce Chinese acquisition and opening Indian APIs plant in JV with Zydus
Article | 04 October 2010
Swiss privately-owned drugmaker Nycomed reached another target in its ambitious plans to expand into emerging market, with the inauguration of ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- New study shows UCB's Neupro reduces NSBP in RLS patient
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
